(Q36714041)

15 August 2017

Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093 (English)

1 reference

medroxyprogesterone acetate

15 August 2017

anti-retroviral agent

0 references

1 reference

1

D Heather Watts

1 reference

15 August 2017

Jeong-Gun Park

2

1 reference

15 August 2017

Susan E Cohn

3

1 reference

15 August 2017

Song Yu

4

1 reference

15 August 2017

Jane Hitti

5

1 reference

15 August 2017

Alice Stek

6

1 reference

15 August 2017

Pamela A Clax

7

1 reference

15 August 2017

Laila Muderspach

8

1 reference

15 August 2017

Juan J L Lertora

9

1 reference

15 August 2017

21 December 2007

1 reference

15 August 2017

1 reference

15 August 2017

77

1 reference

15 August 2017

2

1 reference

15 August 2017

84-90

1 reference

Fat distribution in women with HIV infection

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Injectable hormone contraception and bone density: results from a prospective study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Depressive symptoms and Depo-Provera

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Experiences of injectable contraceptive users in an urban setting

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Depo-Provera use in an Australian metropolitan practice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Contraceptive Use—Efficacy Study Utilizing Medroxyprogesterone Acetate Administered As An Intramuscular Injection Once Every 90 Days

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Reduced bone density in HIV-infected women

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Pregnancy and progression to AIDS: results of the French prospective cohorts. SEROGEST and SEROCO Study Groups

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Continuation rates among injectable contraceptive users

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424313

Factors affecting continuation rates of DMPA

20 October 2018

1 reference

12 December 2020

Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women

1 reference

12 December 2020

Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report

1 reference

12 December 2020

Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS

1 reference

12 December 2020

Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting

1 reference

12 December 2020

Does Pregnancy Influence the Course of HIV Infection?

1 reference

12 December 2020

Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department

1 reference

12 December 2020

10.1016/J.CONTRACEPTION.2007.10.002

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

18226670

1 reference